首页> 外国专利> Alternaria alternata recombinant DNA allergens

Alternaria alternata recombinant DNA allergens

机译:交链孢霉重组DNA变应原

摘要

The invention relates to the complete cDNA sequences of the Alternaria alternata allergenes Alt a 45 and Alt a 12. It has been possible in the course of molecular biological analysis of the allergens to identify Alt a 45 as a protein-disulphide isomerase. This protein is a 45 kD large protein to which 47 % of patients react and is thus an important primary allergen. Alt a 12 (to which 8 % of patients react) was identified as a ribosomal protein which is of interest because auto-antibodies for ribosomal proteins are found in patients suffering from lupus. It remains to be seen whether there is any connection between allergy to mould fungus and autoimmune diseases. Using this recombinant sequence and computer analysis, it has been possible to identify highly potent B- and T-cell epitopes and to use the peptides derived from the recombinant proteins for diagnosis of an allergy to Alternaria alternata mould fungus. The peptides has also proved suitable for both in vitro and in vivo allergen-specific stimulation of T-cells (proliferation, interleukin production), and for blocking the T-cells resulting in a tolerance of the allergen-specific T-lymphocytes.
机译:本发明涉及Alternaria alternata allergenes Alt a 45和Alt a 12的完整cDNA序列。在变应原的分子生物学分析过程中,有可能将Alt a 45鉴定为蛋白质-二硫键异构酶。该蛋白是一种45 kD的大蛋白,有47%的患者对其产生反应,因此是重要的原发性过敏原。 alt 12被认为是一种核糖体蛋白(引起8%的患者反应),这是令人感兴趣的,因为在患有狼疮的患者中发现了核糖体蛋白的自身抗体。霉菌过敏与自身免疫性疾病之间是否有任何联系还有待观察。使用这种重组序列和计算机分析,已经可以鉴定出高效的B细胞和T细胞表位,并将衍生自重组蛋白的肽用于诊断对Alternaria alternata霉菌的过敏。该肽还被证明适用于体外和体内的T细胞过敏原特异性刺激(增殖,白介素的产生),以及阻断T细胞,导致对过敏原特异性T淋巴细胞的耐受性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号